Gene Review:
TAOK2 - TAO kinase 2
Homo sapiens
Synonyms:
KIAA0881, Kinase from chicken homolog C, MAP3K17, PSK, PSK-1, ...
- Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. Hutchison, M., Berman, K.S., Cobb, M.H. J. Biol. Chem. (1998)
- A Kazal prolyl endopeptidase inhibitor isolated from the skin of Phyllomedusa sauvagii. Gebhard, L.G., Carrizo, F.U., Stern, A.L., Burgardt, N.I., Faivovich, J., Lavilla, E., Ermácora, M.R. Eur. J. Biochem. (2004)
- Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Nakazato, H., Koike, A., Saji, S., Ogawa, N., Sakamoto, J. Lancet (1994)
- PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Zhang, H., Morisaki, T., Nakahara, C., Matsunaga, H., Sato, N., Nagumo, F., Tadano, J., Katano, M. Oncogene (2003)
- Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Kawakami, T., Zhang, C., Taniguchi, T., Kim, C.J., Okada, Y., Sugihara, H., Hattori, T., Reeve, A.E., Ogawa, O., Okamoto, K. Oncogene (2004)
- Oryza sativa PSK gene encodes a precursor of phytosulfokine-alpha, a sulfated peptide growth factor found in plants. Yang, H., Matsubayashi, Y., Nakamura, K., Sakagami, Y. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Phytosulfokine-alpha, a sulfated pentapeptide, stimulates the proliferation of rice cells by means of specific high- and low-affinity binding sites. Matsubayashi, Y., Takagi, L., Sakagami, Y. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Effects of OK-432 (picibanil) on the estrogen receptors of MCF-7 cells and potentiation of antiproliferative effects of tamoxifen in combination with OK-432. Aoyagi, H., Iino, Y., Takeo, T., Horii, Y., Morishita, Y., Horiuchi, R. Oncology (1997)
- Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan. Morimoto, T., Ogawa, M., Orita, K., Sugimachi, K., Toge, T., Dohi, K., Nomura, Y., Monden, Y., Ogawa, N. Eur. J. Cancer (1996)
- Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer. Alliot, C. Br. J. Cancer (2004)
- A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. Koda, K., Miyazaki, M., Sarashina, H., Suwa, T., Saito, N., Suzuki, M., Ogawa, K., Watanabe, S., Kodaira, S., Nakazato, H. Int. J. Oncol. (2003)
- kin-18, a C. elegans protein kinase involved in feeding. Berman, K.S., Hutchison, M., Avery, L., Cobb, M.H. Gene (2001)
- PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization. Moore, T.M., Garg, R., Johnson, C., Coptcoat, M.J., Ridley, A.J., Morris, J.D. J. Biol. Chem. (2000)
- Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. García-Lora, A., Martinez, M., Pedrinaci, S., Garrido, F. Cancer Immunol. Immunother. (2003)
- The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. Mitsopoulos, C., Zihni, C., Garg, R., Ridley, A.J., Morris, J.D. J. Biol. Chem. (2003)
- Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2. Chen, Z., Cobb, M.H. J. Biol. Chem. (2001)
- TAO (thousand-and-one amino acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors. Chen, Z., Raman, M., Chen, L., Lee, S.F., Gilman, A.G., Cobb, M.H. J. Biol. Chem. (2003)
- Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor staurosporine. Zhou, T.J., Sun, L.G., Gao, Y., Goldsmith, E.J. Acta Biochim. Biophys. Sin. (Shanghai) (2006)
- Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Basso, D., Valerio, A., Seraglia, R., Mazza, S., Piva, M.G., Greco, E., Fogar, P., Gallo, N., Pedrazzoli, S., Tiengo, A., Plebani, M. Pancreas (2002)
- Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Harada, M., Matsunaga, K., Oguchi, Y., Iijima, H., Tamada, K., Abe, K., Takenoyama, M., Ito, O., Kimura, G., Nomoto, K. Int. J. Cancer (1997)
- Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Ohwada, S., Ikeya, T., Yokomori, T., Kusaba, T., Roppongi, T., Takahashi, T., Nakamura, S., Kakinuma, S., Iwazaki, S., Ishikawa, H., Kawate, S., Nakajima, T., Morishita, Y. Br. J. Cancer (2004)
- Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Kato, M., Hirose, K., Hakozaki, M., Ohno, M., Saito, Y., Izutani, R., Noguchi, J., Hori, Y., Okumoto, S., Kuroda, D. Cancer Immunol. Immunother. (1995)